Race reporting and disparities regarding clinical trials in bladder cancer: a systematic review

ConclusionRace is poorly studied in bladder cancer clinical trials. Trial cohorts may not reflect multicultural populations. The potential association between race and efficacy, safety or tolerability of the tested interventions is unknown. Given the up to twofold increase in bladder cancer-specific death among African-Americans, further research is needed to address the impact of race in clinical trials, while encompassing socioeconomic factors and disease risk factor exposures.
Source: Cancer Causes and Control - Category: Cancer & Oncology Source Type: research